Relationship between metabolism and biomass of medically important zygomycetes

Medical Mycology

Volumn 44, Issue 5, 2006, Pages 429-438

  Antachopoulos, Charalampos ^a   Meletiadis, Joseph ^a   Roilides, Emmanuel ^a,b   Sein, Tin ^a   Sutton, Deanna ^c   Wickes, Brian ^c   Rinaldi, Michael ^c   Merz, William ^d   Shea, Yvonne ^e   Walsh, Thomas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Boltzmann model; Fungal growth; Metabolic activity; XTT; Zygomycetes

Indexed keywords

FUNGAL DNA; MENADIONE;

ABSIDIA; ARTICLE; CONTROLLED STUDY; CUNNINGHAMELLA; CUNNINGHAMELLA BERTHOLLETIAE; DNA DETERMINATION; FUNGAL BIOMASS; FUNGAL METABOLISM; FUNGUS HYPHAE; FUNGUS ISOLATION; IN VITRO STUDY; INCUBATION TIME; LINEAR REGRESSION ANALYSIS; MICROBIAL KINETICS; MUCOR; MUCOR CIRCINELLOIDES; NONHUMAN; RHIZOPUS; RHIZOPUS MICROSPORUS; RHIZOPUS ORYZAE; SPECIES DIFFERENCE; SPECTROPHOTOMETRY; VALIDATION STUDY; ZYGOMYCETES;

HUMANS; MUCORALES; MUCORMYCOSIS; NONLINEAR DYNAMICS; SPECIES SPECIFICITY; SPECTROPHOTOMETRY; TIME FACTORS;

ABSIDIA CORYMBIFERA; CUNNINGHAMELLA BERTHOLLETIAE; MUCOR; MUCOR CIRCINELLOIDES; RHIZOPUS MICROSPORUS; RHIZOPUS ORYZAE; ZYGOMYCETES;

EID: 33746800195     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780600644878     Document Type: Article

References (26)

1. Ribes, JA and Vanover-Sams, CL and Baker, DJ. (2000) Zygomycetes in human disease Clin Microbiol Rev, 13, pp.236-301.
2. Roden, MM and Zaoutis, TE and Buchanan, WL and (2005) Epidemiology and outcome of zygomycosis: A review of 929 reported cases Clin Infect Dis, 41, pp.634-653.
3. Kontoyiannis, DP and Lionakis, MS and Lewis, RE and (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases J Infect Dis, 191, pp.1350-1360.
4. Pagano, L and Offidani, M and Fianchi, L and (2004) Mucormycosis in hematologic patients Haematologica, 89, pp.207-214.
5. Meshulam, T and Levitz, SM and Christin, L and Diamond, RD. (1995) A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT) J Infect Dis, 172, pp.1153-1156.
6. Meletiadis, J and Mouton, JW and Meis, JF and (2001) Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species J Clin Microbiol, 39, pp.4256-4263.
7. Hawser, SP and Norris, H and Jessup, CJ and Ghannoum, MA. (1998) Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents J Clin Microbiol, 36, pp.1450-1452.
8. Hawser, SP and Jessup, C and Vitullo, J and Ghannoum, MA. (2001) Utility of
9. Lionakis, MS and Lewis, RE and Samonis, G and Kontoyiannis, DP. (2003) Pentamidine is active in vitro against Fusarium species Antimicrob Agents Chemother, 47, pp.3252-3259.
10. Lewis, RE and Wiederhold, NP and Klepser, ME. (2005) In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp Antimicrob Agents Chemother, 49, pp.945-951.
11. Yekutiel, A and Shalit, I and Shadkchan, Y and Osherov, N. (2004) In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp Antimicrob Agents Chemother, 48, pp.3279-3283.
12. Kuhn, DM and Balkis, M and Chandra, J and Mukherjee, PK and Ghannoum, MA. (2003) Uses and limitations of the XTT assay in studies of Candida growth and metabolism J Clin Microbiol, 41, pp. 506-508.
13. Rinaldi, MG. (1982) Use of potato flakes agar in clinical mycology J Clin Microbiol, 15, pp.1159-1160.
14. Pincus, DH and Salkin, IF and Hurd, NJ and Levy, IL and Kemna, MA. (1988) Modification of potassium nitrate assimilation test for identification of clinically important yeasts J Clin Microbiol, 26, pp.366-368.
15. Shipper, MAA and Stalpers, JA.(2003) Zygomycetes. The Order Mucorales. In Pathogenic Fungi in Humans and Animals. (pp. 67-125). New York: Marcel Dekker, Inc.
16. White, TJ and Bruns, TD and Lee, SB and Taylor, JW.(1990) Amplification and sequencing of fungal ribosomal RNA genes for phylogenetics. In PCR - Protocols and Applications - A Laboratory Manual. (pp. 315-322). New York: Academic Press.
17. Kurtzman, CP and Robnett, CJ. (1997) Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene J Clin Microbiol, 35, pp.1216-1223.
18. Peterson, SW and Kurtzman, CP. (1990) Phylogenetic relationships among species of the genus Issatchenkia Kudriavzev Antonie Van Leeuwenhoek, 58, pp.235-240.
19. Burnham, KP AD.(2002) Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach 2nd edn. New York: Springer-Verlag.
20. Meletiadis, J and Meis, JF and Mouton, JW and Verweij, PE. (2001) Analysis of growth characteristics of filamentous fungi in different nutrient media J Clin Microbiol, 39, pp.478-484.
21. Meletiadis, J and te Dorsthorst, DT and Verweij, PE. (2003) Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi J Clin Microbiol, 41, pp. 4718-4725.
22. Bai, Z and Harvey, LM and McNeil, B. (2003) Physiological responses of chemostat cultures of Aspergillus niger (B1-D) to simulated and actual oxidative stress Biotechnol Bioeng, 82, pp. 691-701.
23. Bradner, JR and Nevalainen, KM. (2003) Metabolic activity in filamentous fungi can be analysed by flow cytometry J Microbiol Methods, 54, pp. 193-201.
24. Espinel-Ingroff, A and Bartlett, M and Bowden, R and (1997) Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi J Clin Microbiol, 35, pp.139-143.
25. Meletiadis, J and Meis, JF and Mouton, JW and Donnelly, JP and Verweij, PE. (2000) Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method J Clin Microbiol, 38, pp.2949-2954.
26. Gil-Lamaignere, C and Simitsopoulou, M and Roilides, E and (2005) Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes J Infect Dis, 191, pp.1180-1187.